Inhibikase Therapeutics Financial Health
How is Inhibikase Therapeutics's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: IKT's short term assets ($33.9M) exceed its short term liabilities ($4.5M).
Long Term Liabilities: IKT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: IKT is debt free.
Reducing Debt: IKT currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IKT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: IKT has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 71.8% each year.